Last Updated : February 8, 2008
Details
FilesGeneric Name:
Duloxetine hydrochloride
Project Status:
Complete
Therapeutic Area:
Depressive, Major Disorder (MDD)
Manufacturer:
Eli Lilly Canada Inc.
Brand Name:
Cymbalta
Project Line:
Reimbursement Review
Project Number:
SR0125-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Depressive, Major Disorder (MDD)
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : February 8, 2008